期刊
BIOCHEMICAL JOURNAL
卷 476, 期 -, 页码 1995-2016出版社
PORTLAND PRESS LTD
DOI: 10.1042/BCJ20190324
关键词
-
资金
- NIH/NIAID [AI115091]
- MINECO/FEDER EU [SAF2016-77433-R, BFU2016-77427-C2-2-R, BFU2017-92223-EXP]
- CIC bioGUNE through the Severo Ochoa Excellence Accreditation [SEV-2016-0644]
- Jurgen Manchot Foundation
- Basque Government
Bacterial capsules have evolved to be at the forefront of the cell envelope, making them an essential element of bacterial biology. Efforts to understand the Mycobacterium tuberculosis (Mtb) capsule began more than 60 years ago, but the relatively recent development of mycobacterial genetics combined with improved chemical and immunological tools have revealed a more refined view of capsule molecular composition. A glycogen-like a-glucan is the major constituent of the capsule, with lower amounts of arabinomannan and mannan, proteins and lipids. The major Mtb capsular components mediate interactions with phagocytes that favor bacterial survival. Vaccination approaches targeting the mycobacterial capsule have proven successful in controlling bacterial replication. Although the Mtb capsule is composed of polysaccharides of relatively low complexity, the concept of antigenic variability associated with this structure has been suggested by some studies. Understanding how Mtb shapes its envelope during its life cycle is key to developing anti-infective strategies targeting this structure at the host-pathogen interface.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据